Searched for
GLAND PHARMA TARGET PRICE
Gland Pharma shares rally 12% after Q1FY27 profit jumps 47% YoY. Should you buy, sell or hold?Gland Pharma shares rose sharply after Q1FY27 profit rose 47% and revenue grew 20% year-on-year. While strong margins and CDMO growth promp...- Buy, Sell or Hold: Morgan Stanley remains overweight on Bharat Forge; Mirae Asset Sharekhan recommends buy on DEE Development EngineersBrokerages remain positive on select stocks following Q1 FY27 earnings, with Morgan Stanley retaining an Overweight rating on Bharat Forge ...
- Eli Lilly’s Foundayo becomes first oral weight-loss drug approved in UK for diabetesBritain's regulator approved Eli Lilly's Foundayo pill for weight and diabetes. This treatment is not yet available through the NHS in the ...
- Brokerages raise SBI target price after Q1 earnings beatState Bank of India shares faced a 2.2 percent decline on Monday, despite surpassing analysts' expectations for their June-quarter earnings...
- Independence Day 2026: India, which once couldn't make smallpox vaccine, has now crossed a pharma milestone the world can't ignore2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement reflects decad...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Buy, Sell or Hold: Elara Capital raises target price on BEML; Citi remains bullish on Titan CompanyBrokerages remain bullish on BEML, Titan and Fortis Healthcare, citing strong earnings, improving margins and growth prospects. Elara sees ...
- SBI shares rise nearly 2% after Q1 beat. Here's what Nomura, Morgan Stanley and other top brokerages expect nextSBI shares gained 1.55% after the lender reported a 10% YoY rise in Q1 FY27 standalone net profit to Rs 21,121 crore, beating Street estima...
- Nifty above 24,500, but volatility clouds path to 25,000: AnalystsThe Nifty index has moved past a significant resistance level, indicating potential further gains. Analysts suggest buying opportunities on...
- Gland Pharma inks strategic CDMO deal with global pharma firm, eyes $90-100 million annual revenueGland Pharma has signed a strategic Manufacturing and Supply Agreement with a leading global pharmaceutical company for technology transfer...
- Q1 Results Tracker: Tata Motors, Vodafone Idea among 2,045 companies set to announce earnings this weekGoldman Sachs expects the Nifty 50 to rebound to 26,500 by June 2027, above its current record high, as India’s macro backdrop improves. Lo...
- Dividend alert: Jio Financial, Power Grid, HPCL among 90 stocks turning ex-dividend this weekNearly 90 companies, including Jio Financial Services, Power Grid Corporation, HPCL, and Hindustan Aeronautics, will turn ex-dividend betwe...
- Man with a bleeding forehead gets rushed to the hospital. He has no cuts or scratches. Doctor explains what made him bleed: ‘An adrenaline spike can cause…'An internal medicine expert recently shared an anecdote about a patient who started bleeding from the forehead without any wounds or scratc...
- Swiggy shares jump nearly 3% as company targets Rs 10,000 crore adjusted EBITDA by FY31Swiggy shares rose after the company unveiled an ambitious FY31 roadmap targeting Rs 10,000 crore in Adjusted EBITDA. It aims to more than ...
- Stock Radar: Concord Biotech stock showing signs of rebound after falling over 20% from highs; time to buy?Concord Biotech stock shows a breakout from a seven-month consolidation phase. Experts suggest buying the stock for a target above 1,500 le...
- Dr Reddy's Laboratories launches generic Sugammadex injection in the United StatesDr Reddy's Laboratories has launched its generic Sugammadex injection in the United States. This new product reverses muscle relaxant effec...
- Buy, Sell or Hold: Morgan Stanley maintains buy on Maruti Suzuki; Citi retains buy on Sun PharmaGlobal brokerages remained selective on large-cap stocks following the latest round of quarterly earnings, with Citi reiterating its bullis...
- MOFSL stays bullish on Sun Pharma; sees 16% upside on innovation pipelineSun Pharma's June quarter results met analyst expectations, signaling future growth. The company is expanding its specialty and innovative ...
- In 2007, scientists found snakes on Japan's Ishima island didn't just eat toxic toads, they borrowed their toxins for defenseSnakes use toad toxins: Researchers discovered Asian snakes sequester toxins from toxic toads for defense. These snakes store borrowed toxi...
- Gland Pharma gets USFDA nod for generic sugammadex injectionGland Pharma secured USFDA approval for its sugammadex injection generic version. This drug reverses muscle relaxant effects used during su...
Load More
